PlainRecalls
FDA Drug Critical Class I Terminated

SlimeX-15 Capsules, 15 mg, 30-count bottles, Marketed by: Signature Pharmaceuticals Ltd. MUMBAI-400-030 Manufactured in India by: HAB Pharmaceuticals & Research Limited 10-Pharma City, SIDCUL, Selaqui, Dehradun, 248 197

Reported: July 13, 2016 Initiated: December 15, 2015 #D-1146-2016

Product Description

SlimeX-15 Capsules, 15 mg, 30-count bottles, Marketed by: Signature Pharmaceuticals Ltd. MUMBAI-400-030 Manufactured in India by: HAB Pharmaceuticals & Research Limited 10-Pharma City, SIDCUL, Selaqui, Dehradun, 248 197

Reason for Recall

Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, making it an unapproved drug.

Details

Recalling Firm
Bee Extremely Amazed LLC
Units Affected
N/A
Distribution
Nationwide
Location
Jewett, OH

Frequently Asked Questions

What product was recalled?
SlimeX-15 Capsules, 15 mg, 30-count bottles, Marketed by: Signature Pharmaceuticals Ltd. MUMBAI-400-030 Manufactured in India by: HAB Pharmaceuticals & Research Limited 10-Pharma City, SIDCUL, Selaqui, Dehradun, 248 197. Recalled by Bee Extremely Amazed LLC. Units affected: N/A.
Why was this product recalled?
Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, making it an unapproved drug.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 13, 2016. Severity: Critical. Recall number: D-1146-2016.